Literature DB >> 3551960

Absorption of protein via the intestinal wall. A quantitative model.

E Ziv, O Lior, M Kidron.   

Abstract

Intact, biological active insulin and pancreatic RNase can be absorbed from the intestinal lumen into the blood circulation. The absorption is dependent on the addition of bile acid (sodium cholate) and proteinase inhibitor. The quantitative absorption of insulin and pancreatic RNase has been demonstrated in an in situ model. The amount of insulin absorbed after 30 min from the ileum to the mesenteric vein was 0.025% of the initial amount. Sodium cholate (10 mg/ml) and 3000 KIU/ml aprotinin enhanced this absorption by 30 times. The amount of pancreatic RNase which was absorbed from the ileum to the blood was 0.002% of the initial amount during 30 min. Sodium cholate (10 mg/ml) and 3000 KIU/ml aprotinin increased the absorption by a factor of 200. No damage occurred to the intestine during the experimental procedures. The sieving characteristics of the intestinal wall were not altered by the presence of sodium cholate and proteinase inhibitor in the intestinal lumen. These results suggest that sodium cholate and proteinase inhibitors can facilitate the absorption of intact, biologically active proteins across the intestinal wall.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3551960     DOI: 10.1016/0006-2952(87)90411-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

Review 1.  Transport of peptide and protein drugs across biological membranes.

Authors:  J C Verhoef; H E Boddé; A G de Boer; J A Bouwstra; H E Junginger; F W Merkus; D D Breimer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

2.  Degradation of insulin by trypsin and alpha-chymotrypsin.

Authors:  R J Schilling; A K Mitra
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

3.  Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer.

Authors:  Nikhil J Kavimandan; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2007-12-23       Impact factor: 5.875

4.  Morpho-cytochemical and biochemical evidence for insulin absorption by the rat ileal epithelium.

Authors:  M Bendayan; E Ziv; R Ben-Sasson; H Bar-On; M Kidron
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

5.  Design and in vivo evaluation of an oral delivery system for insulin.

Authors:  M K Marschütz; P Caliceti; A Bernkop-Schnürch
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

6.  Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery.

Authors:  B J Aungst; N J Rogers
Journal:  Pharm Res       Date:  1988-05       Impact factor: 4.200

Review 7.  Intranasal insulin. Clinical pharmacokinetics.

Authors:  L Illum; S S Davis
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

8.  Biochemical and morpho-cytochemical evidence for the intestinal absorption of insulin in control and diabetic rats. Comparison between the effectiveness of duodenal and colon mucosa.

Authors:  M Bendayan; E Ziv; D Gingras; R Ben-Sasson; H Bar-On; M Kidron
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

9.  Pharmacodynamics of insulin following intravenous and enteral administrations of porcine-zinc insulin to rats.

Authors:  R J Schilling; A K Mitra
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

10.  Oral insulin delivery by means of solid lipid nanoparticles.

Authors:  Bruno Sarmento; Susana Martins; Domingos Ferreira; Eliana B Souto
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.